Analysis of age and disease status as predictors of thyroid cancer-specific mortality using the surveillance, epidemiology, and end results database

Thyroid

Volumn 25, Issue 1, 2015, Pages 125-132

  Orosco, Ryan K ^a   Hussain, Timon ^a   Brumund, Kevin T ^a,b   Oh, Deborah K ^a   Chang, David C ^c   Bouvet, Michael ^a,b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADULT; AGE; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; DATA BASE; DIFFERENTIATED THYROID CANCER; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RACE; RISK FACTOR; SEX; SURVIVAL PREDICTION; THE SURVEILLANCE EPIDEMIOLOGY AND END RESULT DATABASE; ADENOCARCINOMA; AGED; CANCER GRADING; CANCER REGISTRY; LYMPH NODE METASTASIS; MORTALITY; PAPILLARY CARCINOMA; PATHOLOGY; THYROID GLAND; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGE FACTORS; AGED; CARCINOMA, PAPILLARY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; SEER PROGRAM; THYROID GLAND; THYROID NEOPLASMS;

EID: 84920764434     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2014.0116     Document Type: Article

References (29)

1. Siegel R, Ward E, Brawley O, Jemal A 2011 Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61:212-236.
2. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167.
3. Eustatia-Rutten CF, Corssmit EP, Biermasz NR, Pereira AM, Romijn JA, Smit JW 2006 Survival and death causes in differentiated thyroid carcinoma. J Clin Endocrinol Metab 91:313-319.
4. Wong RM, Bresee C, Braunstein GD 2013 Comparison with published systems of a new staging system for papillary and follicular thyroid carcinoma. Thyroid 23:566-574.
5. Byar DP, Green SB, Dor P, Williams ED, Colon J, van Gilse HA, Mayer M, Sylvester RJ, van Glabbeke M 1979A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer 15:1033-1041.
6. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS 1993 Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050-1057; discussion 1057-1058.
7. Cady B, Rossi R 1988 An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104:947-953.
8. Shaha AR, Loree TR, Shah JP 1994 Intermediate-risk group for differentiated carcinoma of thyroid. Surgery 116:1036-1040; discussion 1040-1031.
9. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) 2010 AJCC Cancer Staging Manual. Seventh edition. Springer, New York.
10. Beahrs O, Myers M 1983 American Joint Committee on Cancer Manual for Staging of Cancer. Second edition. Lippincott, Philadelphia, PA.
11. Oyer SL, Smith VA, Lentsch EJ 2012 Reevaluating the prognostic significance of age in differentiated thyroid cancer. Otolaryngol Head Neck Surg 147:221-226.
12. Halan K 1966 Influence of age and sex on incidence and prognosis of thyroid cancer: Three hundred forty-four cases followed for ten years. Cancer 19:1534-1536.
13. Cady B, Sedgwick C, Meissner W, Bookwalter J, Romagosa V, Werber J 1976 Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg 184:541-553.
14. Lang BH, Lo CY, Chan WF, Lam KY, Wan KY 2007 Staging systems for papillary thyroid carcinoma: A review and comparison. Ann Surg 245:366-378.
15. Tran Cao HS, Johnston LE, Chang DC, Bouvet M 2012A critical analysis of the American Joint Committee on Cancer (AJCC) staging system for differentiated thyroid carcinoma in young patients on the basis of the Surveillance, Epidemiology, and End Results (SEER) registry. Surgery 152:145-151.
16. Jonklaas J, Nogueras-Gonzalez G, Munsell M, Litofsky D, Ain KB, Bigos ST, Brierley JD, Cooper DS, Haugen BR, Ladenson PW, Magner J, Robbins J, Ross DS, Skarulis MC, Steward DL, Maxon HR, Sherman SI 2012 The impact of age and gender on papillary thyroid cancer survival. J Clin Endocrinol Metab 97:E878-887.
17. Nixon IJ, Whitcher M, Palmer FL, Shaha ARM, Shah JP, Patel S, Ganly I 2012 The impact of distant metastases at presentation on prognosis in patients differentiated carcinoma of the thyroid gland. Thyroid 22:884-889.
18. Johnston LE, Tran Cao HS, Chang DC, Bouvet M 2012 Sociodemographic Predictors of survival in differentiated thyroid cancer: Results from the SEER database. ISRN Endocrinol 2012:384707.
19. Gilliland FD, Hunt WC, Morris DM, Key CR 1997 Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 79:564-573.
20. NilubolN, Zhang L, Kebebew E 2013Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin. Thyroid 23:695-702.
21. Hughes CJ, Shaha AR, Shah JP, Loree TR 1996 Impact of lymph node metastasis in differentiated carcinoma of the thyroid: A matched-pair analysis. Head Neck 18:127-132.
22. Cunningham MP, Duda RB, Recant W, Chmiel JS, Sylvester JA, Fremgen A 1990 Survival discriminants for differentiated thyroid cancer. Am J Surg 160:344-347.
23. Cady B, Sedgwick CE, Meissner WA, Bookwalter JR, Romagosa V, Werber J 1976 Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg 184:541-553.
24. Podnos YD, Smith D, Wagman LD, Ellenhorn JD 2005 The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg 71:731-734.
25. Lang BH, Lo CY, Chan WF, Lam KY, Wan KY 2007 Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre. Endocr Relat Cancer 14:29-42.
26. Showalter TN, Siegel BA,Moley JF, Baranski TJ, Grigsby PW 2008 Prognostic factors in patients with well-differentiated thyroid cancer presenting with pulmonary metastasis. Cancer Biother Radiopharm 23:655-659.
27. Sampson E, Brierley JD, Le LW, Rotstein L, Tsang RW 2007 Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer 110:1451-1456.
28. Shaha AR, Shah JP, Loree TR 1997 Differentiated thyroid cancer presenting initially with distant metastasis. Am J Surg 174:474-476.
29. Haq M, Harmer C 2005 Differentiated thyroid carcinoma with distant metastases at presentation: Prognostic factors and outcome. Clin Endocrinol (Oxf) 63:87-93.